Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02317523 · ClinicalTrials.gov registry record · NA
Alzheimer's Caregiver Coping: Mental and Physical Health
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT02317523: Completed NA study, sponsored by University of California, San Diego.
NCT02317523 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02317523, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
This study evaluates the effectiveness of Behavioral Activation (BA) therapy vs Support and Information for reducing risk for emotional and cardiovascular diseases in Alzheimer's caregivers. Half of participants will receive BA and the other half will receive support and information.
Primary Outcome
Flow-Mediated Dilation
Interventions
- BEHAVIORAL Behavioral Activation
- BEHAVIORAL Information and Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
What the finished NCT02317523 record still lists
NCT02317523 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Activation is the first listed.
NCT02317523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02317523 about?
NCT02317523 is a clinical study titled "Alzheimer's Caregiver Coping: Mental and Physical Health". This study evaluates the effectiveness of Behavioral Activation (BA) therapy vs Support and Information for reducing risk for emotional and cardiovascular diseases in Alzheimer's caregivers. Half of participants will receive BA and the other half will receive support and information.
What is the current status of trial NCT02317523?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2014-09. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02317523?
The interventions under investigation include: Behavioral Activation (BEHAVIORAL), Information and Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT02317523?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02317523's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia